4 related articles for article (PubMed ID: 38771986)
1. Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Lin FY; Stuckert A; Tat C; White M; Ruggieri L; Zhang H; Mehta B; Lapteva N; Mei Z; Major A; Thakkar S; Shum T; Parikh K; Wu MF; Lindsay HB; Scherer L; Shekar M; Baxter P; Wang T; Grilley B; Moeller K; Hicks J; Roy A; Anastas J; Malbari F; Aldave G; Chintagumpala M; Blaney S; Parsons DW; Brenner MK; Heslop HE; Rooney CM; Omer B
J Clin Oncol; 2024 May; ():JCO2302019. PubMed ID: 38771986
[TBL] [Abstract][Full Text] [Related]
2.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
3.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
4.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
